BioFront Therapeutics

BioFront is discovering and developing FIC/BIC therapeutics targeting the unmet medical needs in cardiometabolic and vascular diseases, immuno-oncology and oncology. The Company has an innovative DAC platform and more than six early-stage discovery programs